RE:RE:RE:RE:RE:RE:RE:RE:Volume?I am a very long term shareholder who has never posted before.
I am deeply concerned that the share price can't get traction amidst the ongoing studies.
We are repeatedly told that there are collaborations about to be announced, that the science is proving itself, and that there are no competitive threats.
The share price today is less than what I paid seven years ago.
In light of the FDA study, hemophilia study, potential thyroid study, imminent collaborations, etc., it just doesn't reconcile.
The company is now doing a terrible job trying to bolster the stock. The infommercial they produced is very amateur. McWhirter on BNN yesterday didn't even talk about the human trials....how unfortunate. And yes, we have chewed through the IR firms and a bunch of cash.
I was told that we would see a constant barrage of trial updates as the trials would be monitored 24/7. The last, and very lonely press release was unclear and lacking.
I am also very troubled by the fact that a certain promoter/business developer at Sernova has never filed insider reports. I think it would be very relevant for us to see their activity in Sernova stock. I would be particularly interested in what they have been selling.
I have been very supportive of Sernova and Phil over the years but that support is waning.
I now need to see a no-bs update of where we are at, (diabetes, hemophilia, thyroid, collaborations, study costs/funding) and a realistic timeline to fruition. Don't tell me what you think I want to hear, tell us what is happening.